Generic placeholder image

Current Immunology Reviews (Discontinued)

Editor-in-Chief

ISSN (Print): 1573-3955
ISSN (Online): 1875-631X

Mini-Review Article

Can Mandated BCG Vaccine Promote herd Immunity against Novel Coronavirus? A Potential Solution at Hand to Tackle Covid-19 Pandemic

Author(s): Ashok Arasu, Pavithra Balakrishnan, Thirunavukkarasu Velusamy* and Thiagarajan Ramesh

Volume 16, Issue 1, 2020

Page: [6 - 11] Pages: 6

DOI: 10.2174/1573395516999201112092557

Price: $65

Abstract

The 2019 novel coronavirus (2019-nCoV) infection is an emerging pandemic that poses a severe threat to global public health. This pandemic started from the Wuhan City of Hubei Province in China, and is speculated to have originated from bats and spread among humans with an unknown intermediate transmitter. The virus binds to angiotensin-converting enzyme 2 (ACE2), which is abundantly expressed on various human cells, including lung epithelial and intestinal cells, thereby entering into these cells and causing infection. It is transmitted to other humans through airborne droplets from infected patients. Presently there are no specific treatments or vaccines that are available to curtail the spread of this disease. There are few indirect reports that explain the potential importance of the mandated BCG vaccine as a protective factor against COVID-19. There is a speculation that a live attenuated vaccine (BCG vaccine) can be beneficial against COVID-19 to develop the initial immune response, and can also spread in the community, thereby boosting herd immunity to fight against COVID-19. This review summarizes the conclusions of various reports on the BCG vaccine, and is an attempt to establish BCG-vaccination mediated herd immunity as an effective instant intermediate approach in curbing COVID-19 spread in highly populous countries.

Keywords: Coronavirus, COVID-19, Pandemic, ACE2, BCG vaccine, Herd immunity.

Graphical Abstract
[1]
Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet 2020; 395(10223): 470-3.
[http://dx.doi.org/10.1016/S0140-6736(20)30185-9] [PMID: 31986257]
[2]
Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]
[3]
World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it. 2020. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/ technical-guidance/naming-the-coronavirus-disease-(covid-2019)- and-the-virus-that-causes-it
[4]
ICTV. International Committee on Taxonomy of Viruses (ICTV). Available at: https://talk.ictvonline.org/
[5]
Singhal T. A review of coronavirus disease-2019. Indian J Pediatr 2020; 87(4): 281-6.
[http://dx.doi.org/10.1007/s12098-020-03263-6] [PMID: 32166607]
[6]
Miller A, Reandelar MJ, Fasciglione K, Roumenova V, Li Y, Otazu GH. Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study. MedRxiv 2020. Available at: https://www.medrxiv.org/content/10.1101/2020.03.24.20042937v1
[7]
Berg MK, Yu Q, Salvador CE, Melani I, Kitayama S. Mandated Bacillus Calmette-Guérin (BCG) vaccination predicts flattened curves for the spread of COVID-19. Medrxiv 2020. Available at: https://www.medrxiv.org/content/10.1101/2020.04.05.20054163v5
[8]
Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature 1985; 318(6044): 323-9.
[http://dx.doi.org/10.1038/318323a0] [PMID: 3906406]
[9]
Fehr AR, Perlman S. Coronaviruses: an overview of their replication and pathogenesis.Coronaviruses. Springer 2015; pp. 1-23.
[http://dx.doi.org/10.1007/978-1-4939-2438-7_1]
[10]
Hayden FG, Richman DD, Whitley RJ. Clinical virology. ASM Press 2002.
[11]
Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med 2012; 367(19): 1814-20.
[http://dx.doi.org/10.1056/NEJMoa1211721] [PMID: 23075143]
[12]
de Groot RJ, Baker SC, Baric RS, et al. Middle East respiratory syndrome coronavirus (MERS-CoV): announcement of the Coronavirus Study Group. J Virol 2013; 87(14): 7790-2.
[http://dx.doi.org/10.1128/JVI.01244-13] [PMID: 23678167]
[13]
Ksiazek TG, Erdman D, Goldsmith CS, et al. SARS Working Group. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003; 348(20): 1953-66.
[http://dx.doi.org/10.1056/NEJMoa030781] [PMID: 12690092]
[14]
Kuiken T, Fouchier RA, Schutten M, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003; 362(9380): 263-70.
[http://dx.doi.org/10.1016/S0140-6736(03)13967-0] [PMID: 12892955]
[15]
Drosten C, Günther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003; 348(20): 1967-76.
[http://dx.doi.org/10.1056/NEJMoa030747] [PMID: 12690091]
[16]
World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 2003. Available at: https://www.who.int/csr/sars/country/table 2004_04_21/en/
[17]
World Health Organization. Middle East respiratory syndrome coronavirus (MERS-CoV) 2019. Available at: http://www.who.int/emergencies/mers-cov/en/
[18]
Chan JF-W, Kok K-H, Zhu Z, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infect 2020; 9(1): 221-36.
[http://dx.doi.org/10.1080/22221751.2020.1719902] [PMID: 31987001]
[19]
World Health Organization. Novel coronavirus– China. 2020. Available at: https://www.who.int/csr/don/12-january-2020-novel- coronavirus-china/en/
[20]
Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 2020; 579(7798): 270-3.
[21]
Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med 2020; 46(4): 586-90.
[http://dx.doi.org/10.1007/s00134-020-05985-9] [PMID: 32125455]
[22]
World Health Organization. Coronavirus. 2020. Available at: https://www.who.int/health-topics/coronavirus#tab=tab_1
[23]
Jin Y-H, Cai L, Cheng Z-S, et al. for the Zhongnan Hospital of Wuhan University Novel Coronavirus Management and Research Team, Evidence-Based Medicine Chapter of China International Exchange and Promotive Association for Medical and Health Care (CPAM). A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version). Mil Med Res 2020; 7(1): 4.
[http://dx.doi.org/10.1186/s40779-020-0233-6] [PMID: 32029004]
[24]
World Health Organization. Coronavirus disease (COVID-19) Pandemic. 2020. Available at: https://www.who.int/emergencies/diseases/novel- coronavirus-2019
[25]
Unhale SS, Ansar QB, Sanap S, et al. World J Pharmaceut Life Sciences
[26]
World Health Organization. BCG vaccine. 2020. Available at: https://www.who.int/biologicals/areas/vaccines/bcg/en/
[27]
Zimmermann P, Curtis N. The influence of BCG on vaccine responses - a systematic review. Expert Rev Vaccines 2018; 17(6): 547-54.
[http://dx.doi.org/10.1080/14760584.2018.1483727] [PMID: 29882438]
[28]
Uthayakumar D, Paris S, Chapat L, Freyburger L, Poulet H, De Luca K. Non-specific effects of vaccines illustrated through the BCG example: from observations to demonstrations. Front Immunol 2018; 9: 2869.
[http://dx.doi.org/10.3389/fimmu.2018.02869] [PMID: 30564249]
[29]
Covián C, Fernández-Fierro A, Retamal-Díaz A, et al. BCG-induced cross-protection and development of trained immunity. Implication for vaccine design. Front Immunol 2019; 10: 2806.
[http://dx.doi.org/10.3389/fimmu.2019.02806] [PMID: 31849980]
[30]
Kleinnijenhuis J, Quintin J, Preijers F, et al. Long-lasting effects of BCG vaccination on both heterologous Th1/Th17 responses and innate trained immunity. J Innate Immun 2014; 6(2): 152-8.
[http://dx.doi.org/10.1159/000355628] [PMID: 24192057]
[31]
Moorlag SJCFM, Arts RJW, van Crevel R, Netea MG. Non-specific effects of BCG vaccine on viral infections. Clin Microbiol Infect 2019; 25(12): 1473-8.
[http://dx.doi.org/10.1016/j.cmi.2019.04.020] [PMID: 31055165]
[32]
Committee NTA. National Tuberculosis Advisory Committee. The BCG vaccine: information and recommendations for use in Australia. Commun Dis Intell Q Rep 2006; 30(1): 109-15.
[PMID: 16637239]
[33]
Zwerling A, Behr MA, Verma A, Brewer TF, Menzies D, Pai M. The BCG World Atlas: a database of global BCG vaccination policies and practices. PLoS Med 2011; 8(3): e1001012.
[http://dx.doi.org/10.1371/journal.pmed.1001012] [PMID: 21445325]
[34]
Hensel J, McGrail DJ, McAndrews KM, Dowlatshahi D, LeBleu VS, Kalluri R. Exercising caution in correlating COVID-19 incidence and mortality rates with BCG vaccination policies due to variable rates of SARS CoV-2 testing. Medrxiv 2020. Available at: https://www.medrxiv.org/content/10.1101/2020.04.08.200560 51v1
[35]
Urdahl K. The BCG vaccine, used against TB, “could be detrimental” in battling COVID-19: TB expert Kevin Urdahl. The Caravan 2020. Available at: https://caravanmagazine.in/health/bcg- vaccine-covid-immunity-caution
[36]
Betsch C, Böhm R, Korn L, Holtmann C. On the benefits of explaining herd immunity in vaccine advocacy. Nat Hum Behav 2017; 1(3): 1-6.
[http://dx.doi.org/10.1038/s41562-017-0056]
[37]
Coronavirus SB. What Is Herd Immunity And Is It A Possibility For The UK? The Independent. 2020. Available at: https://www.independent.co.uk/life-style/health-and-families/coronavirus-herd-immunity-meaning-definition-what-vaccine-immune- covid-19-a9397871.html
[38]
Randolph HE, Barreiro LB. Herd Immunity: Understanding COVID-19. Immunity 2020; 52(5): 737-41.
[http://dx.doi.org/10.1016/j.immuni.2020.04.012] [PMID: 32433946]
[39]
Regalado A. What is herd immunity and can it stop the coronavirus? MIT Technology Review 2020.
[40]
Kim TH, Johnstone J, Loeb M. Vaccine herd effect. Scand J Infect Dis 2011; 43(9): 683-9.
[http://dx.doi.org/10.3109/00365548.2011.582247] [PMID: 21604922]
[41]
O’Neill LAJ, Netea MG. BCG-induced trained immunity: can it offer protection against COVID-19? Nat Rev Immunol 2020; 20(6): 335-7.
[http://dx.doi.org/10.1038/s41577-020-0337-y] [PMID: 32393823]
[42]
Sanal MG, Duby RC. An oral live attenuated vaccine strategy against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/2019-nCoV). Research Ideas and Outcomes 2020. Available at: https://www.preprints.org/manuscript/202004.01 53/v1

Rights & Permissions Print Export Cite as
© 2022 Bentham Science Publishers | Privacy Policy